TSPO and early-onset autosomal dominant Alzheimer disease: The ligands of TSPO have been evaluated as protective agents to evaluate the inflammatory status in the brains of patients with Alzheimer’s Disease (PK11195 and Ro5-4864)[43], anxiety (XBD-173)[44], MS (PK11195)[45] and acute lung injury (ALI)[7].